Current News
Guillain-Barre syndrome after the first dose of Anti-SARS-CoV-2 vaccination is a rare side effect and the second jab is controversial in these cases
Guillain-Barre syndrome after the first dose of Anti-SARS-CoV-2 vaccination is a rare side effect and the second jab is controversial in these cases 2023-04-11 04:00:00
Residual pulmonary infiltrates, symptoms and diffusion impairment at one-year after severe COVID-19 infection have different associated factors
Residual pulmonary infiltrates, symptoms and diffusion impairment at one-year after severe COVID-19 infection have different associated factors 2023-04-11 04:00:00